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Tissue-resident macrophages play an important role in 
maintaining tissue homeostasis and innate immune defense 
against invading microbial pathogens. Brain-resident 
macrophages can be classified into microglia in the brain 
parenchyma and non-parenchymal brain macrophages, 
also known as central nervous system-associated or border-
associated macrophages, in the brain-circulation interface. 
Microglia and non-parenchymal brain macrophages, 
including meningeal, perivascular, and choroid plexus 
macrophages, are mostly produced during embryonic 
development, and maintained their population by self-
renewal. Microglia have gained much attention for their 
dual roles in the maintenance of brain homeostasis and 
the induction of neuroinflammation. In particular, diverse 
phenotypes of microglia have been increasingly identified 
under pathological conditions. Single-cell phenotypic analysis 
revealed that microglia are highly heterogenous and plastic, 
thus it is difficult to define the status of microglia as M1/M2 
or resting/activated state due to complex nature of microglia. 
Meanwhile, physiological function of non-parenchymal brain 
macrophages remain to be fully demonstrated. In this review, 
we have summarized the origin and signatures of brain-
resident macrophages and discussed the unique features 
of microglia, particularly, their phenotypic polarization, 
diversity of subtypes, and inflammasome responses related to 
neurodegenerative diseases.
Keywords: brain-resident macrophages, central nervous 
system-associated macrophages, inflammasome, microglia, 
non-parenchymal brain macrophages 
INTRODUCTION
The brain has been considered an immune-privileged organ 
because of the protection of the blood-brain barrier and the 
absence of lymphatic vessel drainage (Carson et al., 2006). 
This concept is now being re-evaluated by recent findings 
on immune cell trafficking and the presence of lymphatic 
vessels within surrounding barrier regions (Engelhardt et al., 
2017). Brain parenchymal regions are sequestered from the 
external environment and circulating blood or cerebrospinal 
fluid (CSF) by the meningeal barrier, blood-brain barrier, and 
blood-CSF barrier (Mastorakos and McGavern, 2019). These 
barriers surrounding brain parenchyma prevent the efflux of 
parenchymal antigens and influx of circulating immune cells, 
thereby creating a site that is somewhat secure from periph-
eral immune surveillance (Engelhardt et al., 2017). In the 
brain parenchyma, major cell types are the neurons and glial 
cells, such as the astrocytes, oligodendrocytes, and microglia. 
Among these cells, microglia function as the main immune 
cell that monitor pathogen- or damage-associated molecular 
patterns in the brain (Li and Barres, 2018). In addition to mi-
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croglia, other types of macrophages reside in the surrounding 
barrier or border regions, such as the meninges, perivascular 
space, and choroid plexus stroma. These non-parenchymal 
brain macrophages are also referred to as border-associated 
or central nervous system (CNS)-associated macrophages 
(CAMs) (Kierdorf et al., 2019).
 In pathological conditions, circulating myeloid cells such as 
neutrophils or monocytes can infiltrate into brain parenchy-
ma and some monocytes differentiate into macrophages or 
microglia-like cells. Contrary to these brain-infiltrated macro-
phages, parenchymal microglia and non-parenchymal CAMs 
reside in the brain under normal condition. In this context, 
Fig. 1. Embryonic development of brain-resident macrophages. Between embryonic day 7.0 (E7.0) and E8.0 of mouse development, 
primary erythromyeloid progenitor (EMP) cells in the yolk sac (YS) generate YS macrophages (A1 and A2), which are able to produce 
all types of tissue-resident macrophages including the brain. Around E10.5, YS macrophages move to central nervous system (CNS) or 
peripheral regions, and can differentiate into microglia or non-parenchymal macrophages (perivascular, meningeal, or choroid plexus 
macrophages) in the CNS or YS-derived tissue macrophages in the peripheral tissues. Secondary EMP cells in the YS and hematopoietic 
stem cells (HSCs) in the aorta-gonad-mesonephros (AGM) of embryo migrate to fetal liver during E8.5-10. Then, this fetal liver progenitor 
cells differentiate into fetal liver monocytes, which then invade all peripheral tissues except CNS at E14.5 of embryonic development.
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we categorized microglia and non-parenchymal brain macro-
phages (termed as CAMs) into brain-resident macrophages 
in the current review. Microglia have diverse physiological 
non-immune functions, such as neuronal homeostasis 
regulation and synapse elimination (Li and Barres, 2018). 
Microglia exhibit unique homeostatic phenotypes depend-
ing on the CNS microenvironment (Colonna and Butovsky, 
2017). Under pathological conditions, microglia undergo 
remarkable phenotypic changes into distinct subsets such as 
disease-associated or aged microglia, which are implicated 
in the neurodegenerative diseases, traumatic brain injury, 
and psychiatric diseases (Bar and Barak, 2019; Deczkowska 
et al., 2018; Safaiyan et al., 2016). Therefore, understanding 
of these microglial subsets during disease progression can 
provide significant insights to aid in the development of ther-
apeutic strategies for neurologic disorders.
 Here, we have summarized the development and special-
ized features of the brain-resident macrophages. Moreover, 
we have characterized distinct subtypes of microglia based 
on their regional heterogeneity and plasticity during a disease 
state. Finally, we have discussed the inflammasome respons-
es of microglia related to neurological disorders.
DEVELOPMENT OF BRAIN-RESIDENT MACROPHAGES
Brain-resident macrophages are classified into parenchymal 
microglia and non-parenchymal CAMs, such as meningeal, 
perivascular, and choroid plexus macrophages (Kierdorf et 
al., 2019; Li and Barres, 2018; Mrdjen et al., 2018). Microglia 
represent the largest population of immune cells in the brain 
parenchyma, whereas other cell types are localized at the in-
terface between the brain parenchyma and circulation (Prinz 
et al., 2017). During the development of brain-resident mac-
rophages, three waves of hematopoiesis occur in two major 
sites, yolk sac (YS) and fetal liver. In the first wave, “primitive” 
hematopoiesis generates primary erythro-myeloid progenitor 
(EMP) cells in the YS during embryonic day 7.0 (E7.0) and 
E.8.0 (Sevenich, 2018). Primary EMP cells predominantly 
generate YS macrophages (A1 and A2), which colonize the 
entire embryo to generate all types of tissue-resident mac-
rophages, including those in the brain (Fig. 1) (Ginhoux and 
Guilliams, 2016; Hoeffel et al., 2015; Li and Barres, 2018). YS 
macrophages move to the CNS or peripheral region around 
E10.5 (Li and Barres, 2018; McGrath et al., 2003), then dif-
ferentiate into microglia or non-parenchymal macrophages in 
the CNS and YS-derived tissue macrophages in the peripheral 
tissues.
 In the overlapping second and third waves, “definitive” 
hematopoiesis is initiated by hematopoietic progenitors, sec-
ondary EMPs in the YS and hematopoietic stem cells (HSCs) 
in the aorta-gonad-mesonephros of the embryo, during 
E8.5-E10 (Epelman et al., 2014b). Both progenitor cells mi-
grate into the fetal liver during E9.5-E10.5 and differentiate 
into fetal liver monocytes. At approximately E14.5, the fetal 
liver monocytes invade all surrounding tissues except the 
brain parenchyma, where the blood-brain barrier, formed at 
approximately E13.5, presumably blocks their entry (Frade 
and Barde, 1998; Li and Barres, 2018). Fetal liver monocytes 
then develop into fetal liver-derived tissue macrophages or 
non-parenchymal macrophages in the brain. Notably, the two 
tissue macrophage populations, fetal liver- and YS-derived, 
cannot be distinguished in the peripheral tissues in adults (Li 
and Barres, 2018). Primary EMPs, secondary EMP-derived 
fetal liver monocytes, and HSC-derived fetal liver monocytes 
disproportionately contribute to all tissue macrophages. Fetal 
liver serves as the major hematopoietic organ during defin-
itive hematopoiesis, and around birth, hematopoiesis starts 
being restricted to the bone marrow (Perdiguero and Geiss-
mann, 2016).
 Microglial population of the fetal brain is almost estab-
lished before the onset of monocyte production in the fetal 
liver and blood-brain barrier closure (Ginhoux et al., 2013; 
Sevenich, 2018). Thus, microglia originate exclusively from 
YS-derived progenitors, whereas CAMs are replenished by 
fetal liver-derived progenitor cells during embryonic develop-
ment (Sevenich, 2018). In this way, all brain-resident macro-
phages are predominantly generated by embryonic precursor 
cells and maintain their population by self-renewal under nor-
mal conditions except for the choroid plexus macrophages 
(Li and Barres, 2018). In adults, choroid plexus macrophages 
are further replenished by circulating HSC-derived progenitor 
cells (Fig. 2) (Goldmann et al., 2016; Li and Barres, 2018; 
Prinz et al., 2017).
 Normally, microglia sustain the microglia pool via local 
clonal expansion throughout life (Butovsky and Weiner, 
2018); however, fate-mapping studies have proposed that 
monocyte-derived macrophages, which are recruited into the 
brain parenchyma, can differentiate into the microglial pop-
ulation under certain physiological conditions, while main-
taining their own unique identity (Cronk et al., 2018; Lund 
et al., 2018). In contrast, Huang et al. (2018) demonstrated 
that microglial depletion resulted in repopulation of microglia 
by remaining residual microglia but not by peripheral mac-
rophages. Therefore, at present, it remains unclear whether 
peripheral macrophages can contribute to microglial pool.
Ontogeny of peripheral tissue macrophages
For a long time, it was believed that tissue-resident macro-
phage homeostasis relied on constant recruitment of bone 
marrow-derived blood monocytes (Sawyer et al., 1982; van 
Furth and Cohn, 1968; Volkman et al., 1983). However, 
many ontogenic studies revealed that a majority of tissue 
macrophages originated from embryonic precursors that 
were derived from the YS and fetal liver (Fig. 2) (Ginhoux and 
Guilliams, 2016; Li and Barres, 2018; Sevenich, 2018). Tis-
sue-resident macrophages maintain themselves in adults by 
self-renewal except in the gut, dermis, and heart (Epelman et 
al., 2014a; Tamoutounour et al., 2013). The gut and dermis 
are considered open tissues with fast recruitment kinetics 
and differentiation of bone marrow-derived monocytes into 
macrophages (Ginhoux and Guilliams, 2016). For example, 
although at birth, embryonically derived macrophages are 
present in the gut, they are replaced by cells derived from 
an influx of CCR2-dependent Ly6Chi monocytes (Bain et al., 
2014). Likewise, cardiac macrophages originate from the 
embryonic YS and fetal monocyte progenitors and give rise 
to embryonic resident macrophages; however, they can be 
replenished by bone marrow-derived monocytes, especially 
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after a heart injury such as cardiac ischemia (Fig. 2) (Epelman 
et al., 2014a).
SIGNATURES OF BRAIN-RESIDENT MACROPHAGES
Microglia express common macrophage markers such as 
F4/80, CD11b, CD45, Iba1, and CX3C chemokine receptor 1 
(CX3CR1) (Li and Barres, 2018). Although many of these pro-
teins are expressed by macrophages, their expression levels 
can be used to distinguish microglia from other related cell 
types (Butovsky and Weiner, 2018). For instance, CD45 and 
CD11b are downregulated in microglia than in monocytes, 
which makes it possible to distinguish resident microglia from 
infiltrated monocyte-derived cells in the brain (Bennett et 
al., 2016; Butovsky and Weiner, 2018; Li and Barres, 2018). 
CX3CR1 is expressed in other tissue macrophages; howev-
er, its expression is higher in microglia (Jung et al., 2000). 
Notably, CX3CR1 deficiency leads to transient reduction in 
microglia number during the early postnatal period and a 
consequent defect in synaptic pruning, synaptic transmission, 
and functional brain connectivity (Zhan et al., 2014). It is 
thus widely used to study the role of microglia in the CNS by 
using CX3CR1-deficient or CX3CR1-Cre mouse lines (Reshef 
et al., 2017; Wolf et al., 2013; Zhao et al., 2019). Besides, 
microglia express other highly restricted, specific molecules 
such as transmembrane protein 119 (TMEM119), P2Y puri-
noceptor 12 (P2RY12), and Sal-like protein 1 (SALL1) (Table 
1) (Butovsky and Weiner, 2018; Buttgereit et al., 2016; Li and 
Barres, 2018).
 Some microglial markers exhibit a distinct expression pat-
tern depending on the surrounding environment. Triggering 
receptor expressed on myeloid cells 2 (TREM2) is a crucial 
transmembrane receptor in microglia to scavenge extracel-
lular toxic molecules such as amyloid-β and its expression is 
restricted to some CNS regions (Poliani et al., 2015; Schmid 
et al., 2002). Although TREM2 mutation is considered a risk 
factor for non-familial Alzheimer’s disease (AD), its expression 
does not change in AD patients (Colonna and Wang, 2016; 
Del-Aguila et al., 2019). Additionally, the expression of CD33 
(Siglec3), another transmembrane receptor of microglia, is 
elevated in AD patients, and the increased CD33 expression 
is associated with the inhibition of amyloid-β clearance and 
Fig. 2. Location of brain-resident macrophages. Microglia are the major innate immune cells in the brain parenchyma that are 
exclusively derived from yolk sac (YS)-derived embryonic precursor cells. All other brain-resident macrophages, including meningeal, 
perivascular, and choroid plexus macrophages, which originate from both YS- and fetal liver (FL)-derived progenitor cells, are located at 
the brain-circulation interface. Brain-resident macrophages maintain their population by self-renewal, whereas only the choroid plexus 
macrophages receive input from the circulating hematopoietic stem cell (HSC)-derived progenitors. Cardiac and intestinal macrophages 
also originate from the HSC-derived progenitor cells. Peripheral tissue macrophages in the epidermis and heart are derived from 
embryonic precursors. FL-derived precursor cells are committed to forming Kupffer cells in the liver and alveolar macrophages in the lung. 
CSF, cerebrospinal fluid; CNS, central nervous system.
Mol. Cells 2021; 44(5): 281-291  285
Distinct Features of Brain-Resident Macrophages
Eunju Lee et al.
phagocytosis (Griciuc et al., 2013). CD68, a lysosomal pro-
tein, is highly expressed in activated microglia but not in rest-
ing microglia (Griciuc et al., 2013; Hopperton et al., 2018; 
Walker and Lue, 2015).
 Non-parenchymal CAMs express pan-macrophage mark-
ers similar to those expressed by microglia, such as CX3CR1, 
CD45, CD11b, and Iba1 (Table 1) (Brioschi et al., 2020). Of 
note, higher expression of CD45 and MHCII in CAMs gener-
ally distinguishes them from microglia (Li and Barres, 2018). 
However, the presence of CD45low non-parenchymal brain 
macrophages makes it difficult to discriminate from microglia 
(Mrdjen et al., 2018). Additionally, lymphatic vessel endo-
thelial hyaluronan receptor 1 (LYVE1) was also expressed 
in perivascular and meningeal macrophages, but not in mi-
croglia (Ayata et al., 2018). During embryonic development, 
YS-derived progenitor cells (CD206-positive) can differentiate 
into non-parenchymal macrophages with a specific CD206 
expression at E10.5 (Utz et al., 2020). Choroid plexus macro-
phages that originate from embryonic precursor cells express 
SALL1, whereas monocyte-derived choroid plexus macro-
phages do not (Buttgereit et al., 2016). Moreover, SALL1 
is not expressed in meningeal or perivascular macrophages 
(Buttgereit et al., 2016). Recent studies using single-cell 
sequencing technologies revealed that meningeal and peri-
vascular macrophages are considered as homogenous pop-
ulations, while more heterogeneity was observed in choroid 
plexus macrophages (Jordao et al., 2019; Kierdorf et al., 
2019).
PHENOTYPES AND FUNCTIONS OF MICROGLIA
M1/M2 polarization of macrophages
Tissue-specific or context-dependent microenvironments 
result in diverse macrophage phenotypes that show dis-
tinct gene expression profiles and specific time-dependent 
functions (Ivashkiv, 2013; Lawrence and Natoli, 2011). De-
pending on the extracellular conditions, such as cytokines, 
lipid mediators, or pattern-recognition receptor agonists, 
macrophages can be activated into two groups, M1 and M2 
macrophages, which have distinct phenotypic and functional 
characteristics (Ginhoux et al., 2016; Ivashkiv, 2013). Given 
the intensive efforts to highlight previous works regarding 
M1/M2 polarization, macrophage polarization is not going to 
be rigorously discussed in this review. However, macrophage 
activation status cannot be simply classified into two groups. 
Macrophages do not show a clear M1 or M2 phenotype in 
physiological conditions and instead present with phenotyp-
ic plasticity in many homeostatic or pathological situations 
(Martinez and Gordon, 2014).
Resting and activated microglia
Under normal and physiological conditions, microglia exist in 
a so-called “resting state.” Resting microglia, characterized by 
a highly ramified morphology, continuously attempt to detect 
any pathological or homeostatic changes in the brain pa-
renchyma (Nimmerjahn et al., 2005). On observing a distur-
bance or damage in the CNS homeostasis, the microglia shift 
toward an “activated state.” (Davalos et al., 2005; Kawabori 
and Yenari, 2015) Further, upon sensing foreign molecules 
associated with an infection and damage-associated factors 
from damaged neurons, microglia undergo transformation 
from their resting state to an activated state, which can in 
turn initiate protective or detrimental microglial functions 
(Fig. 3) (Butovsky et al., 2005). However, the nomenclature 
of “resting” and “activated” microglia has been recently chal-
lenged because of the highly dynamic surveillance in the 
resting status (Nimmerjahn et al., 2005; Sierra et al., 2014). 
Interestingly, microglial activation is also controlled by two 
types of signals from neurons, namely, the “on” and “off” sig-
nals (Biber et al., 2007; Szepesi et al., 2018). Neuronal “off” 
signals include constitutive production of CX3CL1, CD22, 
neurotransmitters, or neutrophins from healthy neurons 
to keep the microglia in a resting state (Biber et al., 2007). 
Conversely, damaged or stressed neurons rapidly trigger the 
activation of microglia by producing “on” signals, such as 
CCL21, CCL10, or ATP production. Although microglial acti-
vation can also be classified into M1 and M2 polarization just 
like macrophage activation (Hu et al., 2015; Orihuela et al., 
2016), microglia show more heterogeneous phenotypes than 
peripheral macrophages due to a brain-specific regional dif-
ference and pathological conditions (Ginhoux et al., 2016). 
Thus, neither the terms “resting” and “activated,” nor M1 and 
M2 are sufficient for defining and explaining the complex 
plasticity of microglia.
 Microenvironments in the brain may drive the differenti-
ation of distinct microglial subtypes, resulting in microglial 
regional heterogeneity (Stratoulias et al., 2019). Microglial 
regional heterogeneity includes microglial density, morphol-
ogy, molecular signatures, and functions across different 
brain regions (Tan et al., 2020). Notably, microglial subtypes 
in each brain region respond differently to identical stimuli 
or conditions (Furube et al., 2018; Hui et al., 2018; Tay et al., 
Table 1. Molecular signatures of brain macrophages
Type Name Expression markers
Brain-resident (parenchymal) Microglia CD45int, CD11bint, CX3CR1, IBA1, TMEM119, P2RY12, TREM2, 
SALL1, Siglec-H
Brain-resident (non-parenchymal) Meningeal macrophages CD45hi , CD11b, CX3CR1,  
IBA1, LYVE1, MHCIIhi
CD206, Siglec-1 (CD169), 
CD36Perivascular macrophages
Choroid plexus macrophages SALL1, Siglec-H, CCR2, Ly6Chi
Brain-infiltrated (parenchymal) Monocyte-derived macrophages CD45hi, CD11bhi, IBA1, Siglec-1 (CD169), CCR2, Ly6Chi, CD44 
CX3CR1, CX3C chemokine receptor 1; IBA1, ionized calcium-binding adaptor molecule 1; TREM2, triggering receptor expressed on my-
eloid cells 2; SALL1, Sal-like protein 1; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; CCR2, C-C chemokine receptor 2.
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2017). For example, cerebellar and hippocampal microglia 
exist in a more “immune-vigilant” state than the microglia in 
the forebrain regions (Grabert et al., 2016). Furthermore, 
cerebellar microglia express increased gene expression asso-
ciated with the detection and phagocytosis of apoptotic cells 
than microglia in striatum or cortex (Ayata et al., 2018). Mi-
croglia within the subventricular zone and rostral migratory 
stream exhibit lower expression of purinoreceptors and less 
phagocytic ability than cortical microglia (Ribeiro Xavier et al., 
2015). This distinct microglial phenotype contributes to the 
support of neurogenesis in the subventricular zone. On the 
contrary, microglia in the cortex shows more rapid chemo-
tactic ability towards ATP than subventricular zone microglia 
(Ribeiro Xavier et al., 2015).
Disease-associated and aged microglia
Under pathological conditions, several microglial subtypes, 
such as disease-associated microglia (DAM) and aged mi-
croglia, are reportedly associated with neurodegenerative 
diseases. DAM have been recently identified as a new subset 
of microglia that are found at neurodegeneration sites and 
show unique transcriptional and functional signatures (Dec-
zkowska et al., 2018; Keren-Shaul et al., 2017). DAM show 
downregulation of homeostatic genes such as TMEM19, 
P2RY12, and CX3CR1 and upregulation of TREM2, CST7, 
and Axl (Brioschi et al., 2020). TREM2 signaling plays a piv-
otal role in DAM activation (Keren-Shaul et al., 2017). DAM 
are frequently detected under conditions of accumulating 
degenerating neurons, myelin debris, or extracellular protein 
aggregates and reportedly alleviate the damage; however, it 
is not clear whether they have a protective or disease-induc-
ing function (Butovsky and Weiner, 2018; Haruwaka et al., 
2019; Liddelow et al., 2017; Simard et al., 2006).
 Aging of microglia is also a potent risk factor for the devel-
opment of neurodegenerative diseases. Aged microglia are 
characterized by functional impairment, including decreased 
phagocytic activity, lowered threshold of immune stimuli 
activation, and enhanced release of inflammatory cytokines 
Fig. 3. Diversity of microglial phenotypes. Neuronal “off” signals, such as CX3CL1, constantly inhibit microglial activation in physiological 
conditions. Microglia in this environment show a ramified morphology with a low expression of CD68 and are referred to as “resting” 
microglia. Resting microglia can be activated by PAMPs (LPS) or DAMPs (ATP) inside the CNS into M1-like microglia and are characterized 
by ameboid morphology, high CD68 expression, and proinflammatory phenotypes. Neuronal “on” signals also contribute to M1 
microglial polarization. In contrast, loss of “off” signals or anti-inflammatory cytokine-rich milieu can induce the activation of microglia 
into neuroprotective M2-like phenotype. Recently, diverse microglial phenotypes have been identified in pathological conditions, such 
as DAM, WAM, MGnD and LDAM. PAMP, pathogen-associated molecular pattern; DAMP, damage-associated molecular pattern; LPS, 
lipopolysaccharide.
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(Niraula et al., 2017; Perry and Holmes, 2014; Safaiyan et 
al., 2016; Spittau, 2017). Thus, age-related changes in the 
microglia are likely to be related to the onset and progress 
of age-related neurodegenerative diseases (Spittau, 2017). 
Recently, white matter-associated microglia (WAMs) were 
identified in the white matter of aged mouse brain with a 
similar molecular signature to DAM (Safaiyan et al., 2021). 
Safaiyan et al. (2021) revealed that WAMs are formed in a 
TREM2-dependent, but ApoE-independent manner and re-
quired to remove degenerated myelin. Unlike WAM, TREM2-
ApoE signaling is a major regulator of microglial pheno-
typic change into microglial neurodegenerative phenotype 
(MGnD) in neurodegenerative diseases (Krasemann et al., 
2017). Lipid-droplet-accumulating microglia (LDAM) were 
also recently identified as dysfunctional and proinflammatory 
microglial phenotype in the aged brain (Marschallinger et al., 
2020). Interestingly, LDAM showed impaired phagocytosis 
and might contribute to chronic neuroinflammation and 
neurodegenerative phenotypes (Marschallinger et al., 2020). 
Further research endeavors will likely clarify the correlation of 
these recently-identified disease- or age-associated microglial 
subtypes and the regulation by neuronal on/off signals.
FUNCTIONS OF NON-PARENCHYMAL BRAIN 
MACROPHAGES
Because of their unique anatomical location, non-paren-
chymal CAMs primarily support the barrier function against 
external antigens (Li and Barres, 2018). Although functional 
studies are limited, CAMs reportedly monitor or filter the CSF 
for any harmful antigens and metabolites (Kierdorf et al., 
2019), and also contribute to the drainage of CNS-derived 
antigens (Mundt et al., 2019). CAM-specific markers CD206 
is potentially responsible for their scavenging function (Kier-
dorf et al., 2019). Among brain-circulation barrier regions, 
perivascular spaces in the brain are surrounded by diverse cell 
types, including astrocytes, pericytes and endothelial cells. 
In this context, perivascular macrophages can reciprocally 
interact with these surrounding cells. Of interest, perivas-
cular macrophages drive the activation of hypothalamo-pi-
tuitary-adrenal axis through prostanoid production and the 
anti-inflammatory action on endothelial cells upon systemic 
inflammation (Serrats et al., 2010). Moreover, perivascular 
macrophages can clear amyloid β in a CCR2-dependent 
manner in a mouse model of AD (Mildner et al., 2011). Nev-
ertheless, the physiological function of CAMs is still largely 
unknown and remains to be further elucidated.
 Non-parenchymal CAMs exhibit distinct morphologies. 
Perivascular and meningeal macrophages have more elon-
gated shape than microglia (Kierdorf et al., 2019), whereas 
choroid plexus macrophages are characterized by stellate 
shape similar to Langerhans cells (Goldmann et al., 2016). 
In addition, CAMs in the dura mater, the most outer layer of 
the meninges, have bipolar structure with more dendrites. 
Meanwhile, the phenotypic heterogeneity of CAMs is recent-
ly being examined and thus requires further extensive inves-
tigation. The diversity of CAMs is supported by recent study 
demonstrating the expression of five core signature genes 
including mannose receptor 1 (Mrc1, encoding CD206). In 
particular, the expression of these CAM-specific genes was 
downregulated in the mouse model of neuroinflammation 
(Jordao et al., 2019). Thus, it will be intriguing to clarify the 
phenotypic diversity of CAMs under pathological condition.
INFLAMMASOME-MEDIATED RESPONSE OF 
MICROGLIA
In the brain, interleukin‐1β (IL-1β) and tumor necrosis factor 
α (TNF-α) are the key proinflammatory cytokines that con-
tribute to CNS inflammation (Clausen et al., 2008). TNF-α 
is produced by the engagement of TLRs in glial or myeloid 
cells, with diverse ligands associated with microbial infection 
or neuronal damage (Rodgers et al., 2020). However, active 
IL-1β production requires further cytosolic inflammasome ac-
tivation along with TLR-mediated transcriptional induction of 
pro-IL-1β (Yu and Lee, 2016). Inflammasome assembly results 
in caspase-1 activation, which then induce the maturation 
and gasdermin D-dependent secretion of IL-1β (Evavold et 
al., 2018; Schroder and Tschopp, 2010). Thus, unlike TNF-α, 
mature IL-1β production is restricted to inflammasome-active 
myeloid cells such as the microglia. It remains to be deter-
mined whether inflammasome activation occurs in non-pa-
renchymal brain macrophages, but a previous study reported 
the expression of inflammasome components in the perivas-
cular macrophages (Kawana et al., 2013).
 Inflammasome is normally composed of sensor proteins, 
such as NOD-like receptor (NLR) family, pyrin domain-con-
taining 3 (NLRP3) or CARD domain-containing 4 (NLRC4), 
adaptor protein, apoptosis-associated speck-like protein 
containing a CARD (ASC), and procaspase-1 (Rathinam 
and Fitzgerald, 2016). This inflammasome components 
are assembled only upon the detection of specific inflam-
masome-stimulating agonists by the sensor proteins in the 
cytoplasm (Yu and Lee, 2016). In particular, inflammasome 
activation in microglia has been implicated in neurodegener-
ative disease progression (Labzin et al., 2018). Indeed, NLRP3 
sensor protein is activated by recognizing protein aggregates 
such as amyloid-β and α-synuclein or abnormal endogenous 
metabolites such as 25-hydroxycholesterol in the microglia 
(Codolo et al., 2013; Gordon et al., 2018; Halle et al., 2008; 
Jang et al., 2016; Venegas et al., 2017). This microglial in-
flammasome activation contributes to neuronal cell death, ul-
timately leading to neurodegeneration (Gordon et al., 2018; 
Heneka et al., 2013; Lee et al., 2019). In the brain parenchy-
ma, microglial NLRP3 may function as a key sensor for cellular 
stress-associated molecules resulting from neuronal injury 
and protein inclusions leading to the progression of numer-
ous neurological disorders, such as AD, Parkinson’s disease, 
multiple sclerosis, stroke, and traumatic brain injury (Voet et 
al., 2019; Walsh et al., 2014).
 Microglia show robust NLRP3 expression particularly in 
the presence of lipopolysaccharide (LPS) stimulation (Gustin 
et al., 2015). Other inflammasome sensor proteins such as 
NLRC4 are also detected at lower levels (Walsh et al., 2014). 
However, it is not certain whether sensors other than NLRP3 
are able to induce inflammasome activation in microglia un-
der physiological conditions. Microglial NLRP3 inflammasome 
responses are more persistent than those by macrophages 
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because of a lack of negative regulation of pro-IL-1β expres-
sion (Burm et al., 2015). Burm et al. (2015) raised the possi-
bility that microglial NLRP3 inflammasome signaling may be 
more harmful to the microenvironment than that by macro-
phages due to a persistent inflammasome activation. Intrigu-
ingly, peripheral inflammation impairs the amyloid-β clearing 
ability of microglia through the NLRP3 inflammasome (Tejera 
et al., 2019). This finding suggests that microglial NLRP3 
inflammasome response can alter the microglial phenotype 
contributing to neurodegeneration. Therefore, further under-
standing of microglial inflammasome response should shed 
light on the development of therapeutic strategies that target 
neuroinflammation-mediated neurological disorders.
CONCLUDING REMARKS
Brain-resident microglia continuously surveil the brain to 
detect homeostatic and pathological changes. Along with 
playing a central role in host defense against invading patho-
gens, microglia maintain tissue homeostasis and develop 
inflammation-mediated diseases. Non-parenchymal CAMs 
may strengthen the barrier function at the brain-circulation 
interface to maintain the CNS immune privilege. Although 
microglia and CAMs share many phenotypic features, they 
also have unique functional differences that result in differ-
ent responses to homeostatic and pathological conditions. 
Additionally, microglia exhibit plasticity and regional hetero-
geneity according to a specific surrounding environment. In 
turn, diverse phenotypes of microglia participate differently 
in disease progression by driving different immunological re-
sponses in a disease-associated environment. Therefore, phe-
notypic approaches can provide important insight into elu-
cidating the pathological mechanisms and developing novel 
therapeutic approaches in a variety of inflammatory diseases 
by targeting specific subsets of microglia. Furthermore, brain 
inflammasome activation may contribute to the development 
of neurodegenerative diseases as well as other neurological 
defects (Heneka et al., 2018). It will be thus intriguing to 
investigate molecular mechanisms by which inflammasome 
signaling is implicated in diseases such as sleep and neuropsy-
chiatric disorders.
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